100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss 3 link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Consolidated Statements Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Consolidated Statements Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100080 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Organization and Nature of the Business link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Business Combination link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Reverse Merger with Gemini link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Cash, Cash Equivalents and Restricted Cash link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Other Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Development and License Agreements link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Corporate Restructuring link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Convertible Promissory Notes link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Business Combination (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Other Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Convertible Promissory Notes (Table) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Organization and Nature of the Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Reverse Merger with Gemini - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Reconciliation of Cash and Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Property and equipment, net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Other Accrued Expenses - Summary of Other Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Leases - Schedule of Components of Company's Lease Expense and Other Information (Details 1) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Leases - Schedule of Components of Company's Lease Expense and Other Information (Details 2) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Long-Term Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Long-Term Debt - Summary of Obligations Under the Term Loan Facility (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Long-Term Debt - Scheduled Annual Principal Payments for Term Loan (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Development and License Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Corporate Restructuring - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Stock-Based Compensation - Summary of Fair Value of Stock Option Granted (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 996135 - Disclosure - Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996155 - Disclosure - Income Taxes - Schedule of Reconciliation of the Statutory Federal Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 996165 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996175 - Disclosure - Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996185 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996195 - Disclosure - Net Loss Per Share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996205 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 996215 - Disclosure - Benefit Plans - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996225 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996235 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996245 - Disclosure - Segment Information - Schedule of Significant Segment Expense Categories (Details) link:presentationLink link:calculationLink link:definitionLink 996255 - Disclosure - Segment Information - Schedule of Significant Segment Expense Categories (Parentheticals) (Details) link:presentationLink link:calculationLink link:definitionLink 996265 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Schedule of Carrying Value of Notes Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] AbbVie Deutschland GmbH & Co. KG AbbVie Deutschland GmbH & Co. KG [Member] AbbVie [Member] Statement [Line Items] Statement [Line Items] Consideration Receivable Related to Achievement of Sales Milestones Consideration receivable related to achievement of sales milestones. Consideration receivable related to achievement of sales milestones Liabilities, Fair Value Disclosure [Abstract] Cybersecurity Risk Board of Directors Oversight [Text Block] Development and Regulatory [Member] Development and Regulatory [Member] Development and regulatory. Plan Name Plan Name [Domain] Development First Milestone [Member] Development First Milestone [Member] Development first milestone. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Accounts Payable And Accrued Liabilities [Member] Accounts Payable and Accrued Liabilities [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income: Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Bitopertin [Member] Bitopertin Bitopertin [Member] Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized Expense Net Increase Decrease in Lease Liabilities Related to Lease Modifications and Reassessments Net increase decrease in lease liabilities related to lease modifications and reassessments. Net increase (decrease) in operating lease liabilities related to lease modifications and reassessment events Share-based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Business Combination Business Combination Disclosure [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at December 31, 2024 Shares, Outstanding Balance (in shares) Balance (in shares) Other non-cash items Other Noncash Income (Expense) Other Noncash Income (Expense), Total Other non-cash items Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Clinical Performance Measures [Domain] Clinical Performance Measures domain. Auditor Name Auditor Name William White. William White [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Sublease Expiration Date Sublease expiration date. Sublease expiration date Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Area of Real Estate Property Area of office space 2029 Long-Term Debt, Maturity, Year Five January 2025 Underwritten Offering [Member] January Two Thousand and Twenty Five Underwritten Offering [Member] January two thousand and twenty five underwritten offering. Segment Reporting, Other Segment Item, Amount Other segment items Accrued Liabilities [Abstract] Sale of common stock in at-the-market offerings, (in shares) Stock Issued During Period Sale of Common Stock in At-The-market Offerings, Shares Sale of common stock in at-the-market offerings, Shares. Tax Credit Carryforward, Name [Domain] Leases Lessee, Operating Leases [Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Schedule Of Restructuring And Related Costs [Table] Restructuring Cost [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Changes in Fair Value of the Level 3 Liabilities Related to the Roche Agreement Deferred costs related to at-the-market program and shelf registration Amount of Deferred Costs Related to Long-Term Contracts Sales-based [Member] Sales-based. Sales-based [Member] License agreement. License Agreement [Member] License Agreement [Member] Product and Service Product and Service [Axis] Lender Name Lender Name [Axis] Investment, Name [Domain] Depreciation, Depletion and Amortization, Total Depreciation, Depletion and Amortization Depreciation and amortization Defined Benefit Plan, Roll Forwards [Abstract] Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Person Possessing More than 10% of Voting Power [Member] Person Possessing More Than Ten Percentage Of Voting Power [Member] Person possessing more than 10% of voting power. Employee Stock [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Cybersecurity Risk Management Processes Integrated [Text Block] Interest Expense, Nonoperating Interest Expense, Nonoperating, Total Interest expense Interest expense Equity [Text Block] Stockholders' Equity Development [Member] Development [Member] Development. Title and Position [Axis] Prepayment charge, percentage Loan Prepayment Charge Percentage Loan prepayment charge, percentage. Aggregate costs incurred Aggregate Costs Incurred Under Indirect Expenses Aggregate costs incurred under indirect expenses. Sale of Stock [Domain] Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Long-Term Debt, Gross Principal term loan balance Total Sale of pre funded warrant net proceeds Sale Of Pre Funded Warrant Net Proceeds Sale of pre funded warrant net proceeds. Entity Central Index Key Entity Central Index Key Debt Securities, Available-for-Sale [Line Items] Effective Income Tax Rate Reconciliation 162m Limitation Percent Effective income tax rate reconciliation 162m limitation percent. Section 162(m) limitation Warrant [Member] Warrant [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited Forfeited Sale of pre-funded warrants in registered direct offering Stock Issued During Period Value Sale of Pre-Funded Warrants in Registered Direct Offering Sale of pre-funded warrants in registered direct offering, Value. Auditor Opinion Auditor Opinion [Text Block] Deferred tax assets tax credit. Deferred Tax Assets Tax Credit Tax credits Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Common stock shares issued Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] First Potential Milestone [Member] First potential milestone. First potential milestone [Member] June Two Thousand and Twenty Four Underwritten Offering [Member] June Two Thousand and Twenty Four Underwritten Offering [Member] June two thousand and twenty four underwritten offering. Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Payment of one-time, non-refundable, non-creditable initial license fee Payment Of One Time Non Refundable Non Creditable Initial License Fee Payment of one-time, non-refundable, non-creditable initial license fee. Description of initial ownership limit Description Of Initial Ownership Limit Description of initial ownership limit. 2028 Long-Term Debt, Maturity, Year Four Income Statement [Abstract] Entity Address, State or Province Entity Address, State or Province Accrued End of Term Fee Accrued end of term fee. Accrued end of term fee Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Noncash lease expense. Noncash Lease Expense Non-cash lease expense Loss before income taxes Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Revision of Prior Period Revision of Prior Period [Axis] Increase (Decrease) in Other Accrued Liabilities Other accrued expenses License and stock purchase agreement. License and Stock Purchase Agreement [Member] License and Stock Purchase Agreement [Member] Share based compensation arrangements by shareBased payment award options assumed in reverse recapitalization in period weighted average exercise price. Share Based Compensation Arrangements By ShareBased Payment Award Options Assumed In Reverse Recapitalization In Period Weighted Average Exercise Price Assumed in reverse recapitalization Capitalized licenses. Capitalized Licenses Capitalized licenses Common stock reserved for the exercise of pre-funded warrants Stock Reserved During Period Shares Exercise Of Prefunded Warrants Stock reserved during period shares exercise of prefunded warrants. Marketable Securities Marketable Securities, Total Marketable Securities Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series B convertible preferred stock. Share-Based Compensation Arrangement by Share-Based Payment Award, Other Share Increase (Decrease) Debtor Reorganization Items, Impairment Loss Charges for credit-related impairments Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at December 31, 2024 Payments of Debt Issuance Costs Payment of debt issuance costs Payment of debt issuance costs Investors Or Affiliates [Member] Investors Or Affiliates [Member] Investors Or Affiliates [Member] Mabwell Therapeutics Inc [Member] Mabwell Therapeutics, Inc. Mabwell [Member] Cover [Abstract] Subsequent Event [Line Items] Comprehensive Income, Policy [Policy Text Block] Comprehensive Income (Loss) Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per share, basic Debt Issuance Costs, Gross Unamortized deferred financing costs Valuation allowance, deferred tax asset, increase Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Contribution rate per participant's salary Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate Operating expenses: Operating Expenses [Abstract] Series Seed convertible preferred stock Series Seed convertible preferred stock [Member] Series Seed Convertible Preferred Stock [Member] Document Annual Report Document Annual Report Payment for annual license fee Payment For Annual License Fee Payment for annual license fee. Exercise Of Pre-funded Warrants Shares Exercise of pre-funded warrants shares. Exercise of pre-funded warrants shares Accrued External Research And Development Expenses Current The amount of accrued external research and development expenses current. Accrued external research and development expenses Summary of Reconciliation of Cash and Cash Equivalents and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Share-based Payment Arrangement, Expense Share-Based Payment Arrangement, Expense Stock-based compensation expense Stock-based compensation expense Debt Instrument Covenant Minimum Credit Outstanding Debt instrument covenant minimum credit outstanding. Aggregate minimum principal amount Additional consideration upon achievement of certain sales milestones Additional Consideration Upon Achievement Of Certain Sales Milestones Additional consideration upon achievement of certain sales milestones. Long-Term Debt Principal term loan balance Long-term debt, net Long-term debt, net Share based compensation outstanding shares Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Commitments And Contingencies Details [Table] Commitments And Contingencies Details [Table] Commitments and Contingencies (Details) [Table] Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit) Shares issued upon exercise of warrants Stock Issued During Period Shares Warrants Exercised Stock issued during period shares warrants exercised. Issuance of common stock upon exercise of warrants Plan Name Plan Name [Axis] Segment Reporting [Abstract] Stock issuance costs. Stock Issuance Costs Stock issuance costs DISC Zero Nine Seven Four [Member] DISC zero nine seven four. DISC-0974 [Member] Share based compensation outstanding shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding at December 31, 2023 Outstanding at December 31, 2024 Stock Issued During Period Value Sale Of Common Stock In Follow On Public Offering Stock Issued During Period Sale Of Common Stock In Follow On Public Offering Sale of common stock in follow-on public offering Net proceeds after deducting offering expenses Net Proceeds After Deducting Offering Expenses Net proceeds after deducting offering expenses. Current assets: Assets, Current [Abstract] Common Stock, Capital Shares Reserved for Future Issuance Number of shares of common stock reserved Common stock reserved and available for future issuance Schedule Of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan [Table] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Product and Service Product and Service [Domain] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Debt Instrument [Line Items] Debt Instrument [Line Items] Operating loss carryforwards Operating Loss Carryforwards, Total Operating Loss Carryforwards Share-Based Compensation Arrangement by Share-Based Payment Award, Description Share based compensation description Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net Lessee, Operating Lease, Liability, to be Paid, Year Four 2028 Person Possessing Less than 10% of Voting Power [Member] Person Possessing Less Than Ten Percentage Of Voting Power [Member] Person possessing less than 10% of voting power. Additional consideration upon achievement of certain commercial milestones Additional Consideration Upon Achievement Of Certain Commercial Milestones Additional consideration upon achievement of certain commercial milestones. Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Restructuring and Related Activities [Abstract] Vesting Vesting [Axis] Common stock, par value (in Dollars per share) Common Stock, Par or Stated Value Per Share Common stock share exchange value Options to Purchase Common Stock [Member] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] DISC Three Four Zero Five [Member] DISC three four zero five. DISC-3405 [Member] Balance Balance Temporary Equity, Carrying Amount, Attributable to Parent Summary of Shares Issued from Business Combination Disclosure Of Summary Of Shares Issued From Business Combination Table [Text Block] Tabular disclosure of summary of shares issued from business combination. Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive loss: Loan Prepayment Charge Percentage After Eighteen Months Loan prepayment charge percentage after eighteen months. Prepayment Charge, Percentage After Eighteen Months Statement of Cash Flows [Abstract] Counterparty Name [Axis] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Reduction To Additional Paid In Capital [Member] Reduction To Additional Paid In Capital [Member] Reduction to additional paid-in capital. Selling, General and Administrative Selling, General and Administrative Expenses [Member] Entity Entity [Domain] Jefferies LLC ATM Agreement [Member] Jefferies LLC ATM agreement. Jefferies LLC ATM Agreement [Member] Restructuring Costs, Total Restructuring costs Restructuring Costs Restricted Stock [Member] Restricted Common Stock [Member] Equity Components Equity Components [Axis] Entity Address, Address Line One Entity Address, Address Line One Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of Computation of Basic and Diluted Net Loss Per Share Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Accrued employee-related expenses Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Computer Equipment [Member] Computer Equipment [Member] Nonqualified Stock Options [Member] Nonqualified stock options. Nonqualified Stock Options [Member] 2018 Master License Agreement [Member] Two Thousand And Eighteen Master License Agreement [Member] Two thousand and eighteen master license agreement. Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Subsequent Event Type [Axis] Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Tax benefit from the exercise of options eligible for a tax deduction Upfront non-refundable payment. Upfront Non-refundable Payment Non-refundable upfront payment Nonoperating Income (Expense) Total other income (expense), net Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Term loan facility Line of Credit Facility, Maximum Borrowing Capacity Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Sale of pre-funded warrant, price per warrant Pre-funded warrant, price per warrant. Sale of pre-funded warrant, price per warrant Operating Lease Liability Increase Operating lease liability increase. Additional lease liability Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Marketable Securities Non Cash Interest Expense Non-cash interest expense Non cash interest expense. Unvested at December 31, 2021 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unvested at the end of the period Unvested at the beginning of the period Entity Voluntary Filers Entity Voluntary Filers Amendment Flag Amendment Flag Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Stock-based compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Increase (Decrease) in Operating Lease Liability Operating lease liabilities Percentage of workforce. Percentage of workforce Percentage of Workforce Future milestone payment. Future Milestone Payment Future milestone payment Operating Lease, Liability, Noncurrent Operating lease liabilities, non-current Federal Domestic Tax Jurisdiction [Member] Sale of Stock, Price Per Share Sale of common stock, price per share Operating Lease Liabilities Operating Lease Liabilities Operating lease liabilities Net loss Net loss Net loss Lessee, Lease, Description [Table] Pre-funded warrants outstanding. Pre-funded warrants outstanding Pre-funded warrants outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised Issuance of common stock upon exercise of stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at December 31, 2024 Variable Rate Variable Rate [Domain] Research and Development Research and Development Expense [Member] Equity Component Equity Component [Domain] Statistical Measurement Statistical Measurement [Domain] Segment Reporting, Other Segment Item, Composition, Description Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Interest Expense, Debt, Total Interest expense Interest Expense, Debt Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Other expense Expiration period of incentive plan Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Term Loan Exit Fee Rate Term loan exit fee rate Term loan exit fee rate Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Furniture and Fixtures [Member] Furniture and Fixtures [Member] 2019 License Agreement [Member] Two Thousand And Nineteen License Agreement [Member] Two thousand and nineteen license agreement. Cybersecurity Risk Management Processes Integrated [Flag] Preferred Stock, Shares Issued, Total Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock issued Operating Lease, Payments Operating cash flows used in operating leases Cash paid for amounts included in the measurement of operating lease liabilities Proceeds from Stock Options Exercised Proceeds from stock option exercises Accounts Payable and Accrued Liabilities, Total Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Jefferies LLC November 2023 ATM Agreement [Member] Jefferies L L C November 2023 A T M Agreement [Member] Jefferies L L C November 2023 A T M Agreement. Additional consideration of contingent upon future commercialization Additional Consideration Of Contingent Upon Future Commercialization Additional consideration of contingent upon future commercialization. Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under employee stock purchase plan (in shares) Line of Credit Facility, Initial Borrowing Capacity Line of credit facility initial borrowing capacity. Borrowed an initial term loan facility Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Options vested and expected to vest at December 31, 2021 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Offering expenses Offering Expenses Offering expenses. Operating Lease Right of Use Asset Increase Operating lease right of use asset increase. Additional right-of-use asset Restricted Cash, Noncurrent Restricted cash Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Class of Stock Class of Stock [Domain] Severance cost Severance Costs Collaborative Arrangement Disclosure [Text Block] Development and License Agreements Other Research [Member] Other research. Other Research [Member] Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Contingent Consideration by Type [Axis] Net of commissions Net Of Commissions Net of commissions. Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in Dollars per share) Deferred Tax Asset, In-Process Research and Development Research and experimental expenditures Maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Second potential milestone. Second Potential Milestone [Member] Second Potential Milestone [Member] Antidilutive Securities Antidilutive Securities [Axis] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Lease Expiration Date Lease expiration date Significant Segment Expense Category [Member] Significant segment expense category. Significant Segment Expense Category [Member] Marketable Securities [Table Text Block] Schedule of Marketable Securities Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total cash, cash equivalents and restricted cash as shown on the consolidated statements of cash flows Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Receivable for proceeds from stock option exercises included in other current assets Receivable for Proceeds From Stock Option Exercises Included in Other Current Assets 1 Receivable for Proceeds From Stock Option Exercises Included in Other Current Assets 1 Related Party Transactions Related Party Transactions Disclosure [Text Block] Balance Sheet Location Statement of Financial Position Location, Balance [Axis] Undiscounted Lease Payments Due Net Undiscounted lease payments due, net Undiscounted lease payments due, net Statistical Measurement Statistical Measurement [Axis] Research Research Tax Credit Carryforward [Member] Operating lease costs Operating Lease, Cost Stock-based Compensation Stockholders' Equity, Policy [Policy Text Block] Assets, Fair Value Disclosure Total assets Related Party Related and Nonrelated Parties [Domain] Total lease expense Lease, Cost Annual non-refundable, non-creditable development fee payment Annual Non Refundable Non Creditable Development Fee Payment Annual non-refundable, non-creditable development fee payment. Summary of Net Proceeds from Business Combination Disclosure Of Summary Of Net Proceeds From Business Combination Table [Text Block] Tabular disclosure of summary of net proceeds from business combination. Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Future Minimum Lease Payments Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares available for options grant 2015 Plan [Member] Two Thousand Fifteen Plan [Member] Two thousand fifteen plan. Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted-Average Remaining Period of Recognition Net proceeds from issuance of private placement Proceeds from Issuance of Private Placement Employer contribution to plan Defined Benefit Plan, Plan Assets, Contributions by Employer Deferred Tax Assets, Net Total deferred tax assets, net of valuation allowance Net deferred tax assets SVB Securities LLC ATM Agreements [Member] SVB securities LLC ATM agreements member. SVB Securities LLC ATM Agreement [Member] Research and Development Expense, Policy [Policy Text Block] Research and Development Expenses Income Statement Location Statement of Income Location, Balance [Axis] Future consideration recievable on clinical Future Consideration Recievable on Clinical Future consideration recievable on clinical. Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Total assets Assets Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Sale of common stock in at-the-market offerings Stock Issued During Period Value Sale of Common Stock in At-The-market Offerings Sale of common stock in at-the-market offerings, Value. Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Deferred Tax Liabilities, Gross Total deferred tax liabilities Total deferred tax liabilities Vested Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Recently Adopted and Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Revision of Prior Period, Adjustment Revision of Prior Period, Adjustment [Member] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income [Member] Consideration Receivable Related to Achievement of Certain Clinical Consideration receivable related to achievement of certain clinical. Consideration receivable related to achievement of certain clinical Segments [Axis] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Auditor Location Auditor Location Purchase of common stock for pre-funded warrants, shares Purchase of common stock for pre-funded warrants, shares Purchase of common stock for pre-funded warrants, shares Effective Income Tax Rate Reconciliation, Percent [Abstract] Schedule of Maturities of Long-Term Debt [Table Text Block] Scheduled Annual Principal Payments for Term Loan Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Founders and certain employees member. Founders And Certain Employees [Member] Founders And Certain Employees [Member] Debt Instrument, Face Amount Debt Instrument, Face Amount Aggregate principal amount Options vested and expected to vest at December 31, 2021 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Benefit Plans Defined Benefit Plan [Text Block] Restructuring Cost And Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Depreciation Depreciation, Total Depreciation expense Fair value of the underlying instrument Share Price Fair value per share of common stock Revision of Prior Period Revision of Prior Period [Domain] Offering Costs Deferred Charges, Policy [Policy Text Block] Deferred Transaction Costs Schedule of Segment Reporting Information, by Segment [Table] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Aggregate future offer, issuance and sale, Shares Sale of Stock Agreement, Aggregate Future Offer, Issuance and Sale, Shares Maximum aggregate future offer, issuance and sale of shares as agreed upon. Private Placement [Member] Registered Direct Offering [Member] One-time milestone payments One Time Milestone Payments One-time milestone payments. Equity incentive plans Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Sale of pre-funded warrants in follow-on public offering Stock Issued During Period Value Sale Of Pre Funded Warrants In Follow On Public Offering Stock Issued During Period Value Sale Of Pre Funded Warrants In Follow On Public Offering Series A Preferred Stock [Member] Series A [Member] Series A Convertible Preferred Stock [Member] Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Percentage of change in ownership Percentage Of Change In Ownership Percentage of change in ownership. Fair Value Disclosures [Abstract] Hercules Loan Agreement [Member] Hercules Loan Agreement [Member] Hercules loan agreement. Entity Public Float Entity Public Float Aggregate offering price Stock Issued During Period, Value, New Issues Issuance of common stock Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets, net of valuation allowance Unvested Restricted Stock [Member] Unvested restricted stock. Unvested Restricted Common Stock [Member] Future Consideration Recievable on Regulatory Future consideration recievable on regulatory. Future consideration recievable on regulatory Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Lessee, Lease, Description [Line Items] Current liabilities: Liabilities, Current [Abstract] Lease Contractual Term [Axis] At the Market Program and Shelf Registration [Member] At the Market Program and Shelf Registration [Member] At the market program and shelf registration. Income Taxes Paid, Net, Total Income Taxes Paid, Net Cash paid for income taxes Document Type Document Type US Government Agencies Debt Securities [Member] US Government Agencies Debt Securities [Member] Asset Impairment Charges, Total Asset Impairment Charges Asset impairment charges Impairment losses Title of 12(b) Security Title of 12(b) Security Cash and cash equivalents for operations Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value Balance Sheet Location Statement of Financial Position Location, Balance [Domain] Lessee, Operating Lease, Liability, to be Paid, Year Five 2029 Lease, Cost [Table Text Block] Schedule of Components of Company's Lease Expense and Other Information Cybersecurity Risk Management, Strategy, and Governance [Line Items] Statement of Stockholders' Equity [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Deferred Tax Assets, Tax Credit Carryforwards, Research Research and development tax credits carryforwards Research and Development Expense, Total Research and development expense Research and Development Expense Research and development Research and development personnel-related expense Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Percentage of outstanding shares of common stock Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross Property and equipment Subsequent Event Type [Domain] Deferral Agreement [Member] Deferral Agreement [Member] Deferral agreement. Preferred Stock Table Text Block Preferred Stock Table Text Block Summary of Preferred Stock Authorized Issued and Outstanding Lessee, Leases [Policy Text Block] Leases Schedule of stock options granted to employees and non-employees Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Fair Value of Stock Option Granted Pre-funded warrants in registered direct offering, net of issuance costs Pre-Funded Warrants in Registered Direct Offering, Net of Issuance Costs Pre-funded warrants in registered direct offering, net of issuance costs. Schedule of Property and Equipment Estimated Useful Lives Property And Equipment Estimated Useful Lives Table [Text Block] Property and equipment estimated useful lives. Common Stock In Follow On Public Offering Net Of Issuance Costs Common Stock In Follow On Public Offering Net Of Issuance Costs Common stock in follow-on public offering, net of issuance costs Financial Instruments [Domain] Sale of Stock [Axis] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Amortization of Debt Discount and Issuance Costs Policy [Policy Text Block] Amortization of debt discount and issuance costs policy. Amortization of Debt Discount and Issuance Costs Commitments And Contingencies Details [Line Items] Commitments And Contingencies Details [Line Items] Commitments and Contingencies (Details) [Line Items] Oak Bay Biosciences, Inc [Member] Oak Bay Biosciences, Inc. OBB [Member] Marketable Securities, Current Marketable securities 2017 Plan [Member] Two Thousand Seventeen Old Gemini Equity Incentive Plan [Member] 2017 Old Gemini equity incentive plan. Income Taxes Income Tax Disclosure [Text Block] Schedule of Reconciliation of the Statutory Federal Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Term Loan Term Loan [Member] Term loan. Line Of Credit Facility [Line Items] Line of Credit Facility [Line Items] Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Selling, general and administrative Selling, general and administrative expense Selling, general and administrative expense Series B Preferred Stock [Member] Series B [Member] Series B Convertible Preferred Stock [Member] Sale of common stock in registered direct offering, (in shares) Stock Issued During Period Sale of Common Stock in Registered Direct Offering, Shares Sale of Common Stock in Registered Direct Offering, Shares. Credit Facility Credit Facility [Domain] Patent Costs Patent Costs Policy [Text Block] Patent costs. Debt Securities, Available-for-Sale [Table] Accrued other Other Accrued Liabilities, Current Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Purchases of property and equipment included in accounts payable and accrued expenses Noncash or Part Noncash Acquisition, Fixed Assets Acquired Document Period End Date Document Period End Date Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities One-time, non-refundable upfront payment One Time Non Refundable Upfront Payment One-time, non-refundable upfront payment. ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Effective income tax rate Percentage of tax benefit to be recognized Effective Income Tax Rate Reconciliation, Percent Stockholders' Equity Note [Abstract] Contingent Payments. Contingent Payments Contingent payments Future Milestone Recievable Future milestone recievable. Future milestone recievable Aggregate offering, issuance and sale under sales agreement Sale of Stock Agreement, Maximum Aggregate Proceeds Value of stock that is to be offered, issued and sold in a sale agreement. Common stock in registered direct offering, net of issuance costs Common Stock in Registered Direct Offering, Net of Issuance Costs Common stock in registered direct offering, net of issuance costs. Sale of common stock in registered direct offering Stock Issued During Period Value Sale of Common Stock in Registered Direct Offering Sale of Common Stock in Registered Direct Offering, Value. Antidilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Convertible Preferred Stock Text Block Convertible Preferred Stock Convertible preferred Stock. Equity Method Investment, Ownership Percentage Ownership of investors in company's capital stock Purchase price Sale of Stock, Consideration Received on Transaction Sale of common stock, gross proceeds Accrued Liabilities, Current Accrued expenses Other accrued expenses Total other accrued expenses Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Income tax expense Income tax expense Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) State income tax expense Capitalized Deferred Offering Cost [Member] Capitalized Deferred Offering Cost [Member] deferred offering cost member. Deferred tax assets: Components of Deferred Tax Assets [Abstract] Trading Symbol Trading Symbol Business Combinations [Abstract] Variable Rate Variable Rate [Axis] Total stockholders' equity Balance Balance Equity, Attributable to Parent Roche Roche [Member] Roche [Member] Common stock in at-the-market offerings, net of issuance costs Common Stock in At-The-Market Offerings, Net of Issuance Costs Common stock in at-the-market offerings, net of issuance costs. Deferred Tax Assets, Gross Total deferred tax assets Total deferred tax assets Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock [Member] Series A convertible preferred stock. Merger disclosure. Merger Disclosure [Text Block] Reverse Merger with Gemini Percentage of common stock outstanding. Percentage of Common Stock Outstanding Percentage of common stock outstanding State income tax expense State and Local Income Tax Expense (Benefit), Continuing Operations State and Local Income Tax Expense (Benefit), Continuing Operations, Total Restricted Stock Units (RSUs) [Member] Restricted stock units [Member] Number of shares subscribed (in shares) Sale of Stock, Number of Shares Issued in Transaction Sale of common stock, shares Related Party Transactions [Abstract] Stock Issued During Period Sale Of Common Stock In Follow-on Public Offering Shares Stock Issued During Period Sale Of Common Stock In Follow-on Public Offering Shares Sale of common stock in follow-on public offering, (in shares) Non refundable upfront fee. Non Refundable Upfront Fee Non refundable upfront fee Variable Lease, Cost Variable lease costs Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Cybersecurity Risk Management, Strategy, and Governance [Table] Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Goodwill Goodwill or intangible assets recognized Additional consideration upon achievement of certain development and commercial milestones Additional Consideration Upon Achievement Of Certain Development And Commercial Milestones Additional consideration upon achievement of certain development and commercial milestones. Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized Expense Cash and Cash Equivalents Disclosure [Text Block] Cash, Cash Equivalents and Restricted Cash Consideration Receivable Related to Achievement Consideration receivable related to achievement. Consideration receivable related to achievement Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Summary of Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Contingent annual fee upon commercialization description Contingent Annual Fee Upon Commercialization Description Contingent annual fee upon commercialization description. Security Deposit Security deposit Options vested and expected to vest at December 31, 2021 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Unrecognized Compensation Cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Leases [Abstract] Laboratory Equipment Equipment [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Final end of term charge accrued Final End Of Term Charge Accrued Final end of term charge accrued. Proceeds from issuance of long-term debt, net of issuance costs paid Proceeds from Issuance of Long-Term Debt Proceeds from Issuance of Long-Term Debt, Total Additional consideration upon achievement of certain development milestones Additional Consideration Upon Achievement Of Certain Development Milestones Additional consideration upon achievement of certain development milestones. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Class of Stock [Line Items] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Marketable Securities, Policy [Policy Text Block] Marketable Securities Security Exchange Name Security Exchange Name Net of costs incurred paid in form of common stock Common Stock Dividends Income Statement Impact Common stock dividends income statement impact. Counterparty Name [Domain] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Business Acquisition, Acquiree Business Acquisition, Acquiree [Domain] Total operating expenses Operating Expenses Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Tenant improvement allowance Tenant Improvement Allowance Tenant improvement allowance. Follow-On Public Offering [Member] Follow-On Public Offering [Member] Follow-On Public Offering. Class of Stock Class of Stock [Axis] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Legal Entity Legal Entity [Axis] Development and Regulatory Milestone First Indication [Member] Development and regulatory milestone first indication. Development and Regulatory Milestone First Indication [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Internally Developed Software Internally Developed Software [Member] Lessee, Operating Lease, Liability, to be Paid, Year Three 2027 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event [Member] Subsequent Event [Member] Maximum [Member] Maximum [Member] Maximum Corporate Restructuring Restructuring and Related Activities Disclosure [Text Block] Liabilities and Equity Total liabilities and stockholders' equity Operating Lease, Right-of-Use Asset Operating right-of-use assets Operating right-of-use assets Right-of-use assets, operating leases Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Prime Rate [Member] Prime Rate [Member] 2017 Private Disc Plan [Member] Two Thousand Seventeen Private Disc Plan [Member] Two thousand seventeen private disc plan. Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per share, diluted Pre-funded Warrant Beneficiary Ownership Limitation Percentage Under the Notice Period Pre-funded warrant, beneficiary ownership limitation percentage under the notice period. Pre-funded warrant, beneficiary ownership limitation percentage under the notice period Leasehold Improvements [Member] Leasehold Improvements [Member] 2021 Inducement Plan [Member] Two Thousand And Twenty One Inducement Plan [Member] 2021 Inducement Plan. Entity Ex Transition Period Entity Ex Transition Period Total liabilities Liabilities Contingent annual fee upon commercialization amount of net sales Contingent Annual Fee Upon Commercialization Amount Of Net Sales Contingent annual fee upon commercialization amount of net sales. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture, Total Stock-based compensation expense Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Tranche Four [Member] Tranche four. Tranche Four [Member] Total current assets Assets, Current Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Milestone Payments Milestone payments. Milestone payments Loan Prepayment Charge Percentage Thereafter Loan prepayment charge percentage thereafter. Prepayment Charge, Percentage Thereafter Stock Issued During Period, Shares, New Issues Common stock issued Issuance of common stock shares Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Unrecognized Tax Benefits Unrecognized tax benefits Stock Issued During Period Value Sale of Common Stock in Underwritten Offering Stock issued during period value sale of common stock in underwritten. Offering Sale of common stock in an underwritten offering Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in deferred tax asset valuation allowance Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Entity Filer Category Entity Filer Category Property, Plant and Equipment [Abstract] Two Thousand Twenty One Stock Option And Incentive Plan [Member] 2021 Stock Option and Incentive Plan [Member] 2021 Plan [Member] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Nature of the Business Payments to Acquire Marketable Securities Purchases of marketable securities Nonoperating Income (Expense) [Abstract] Other income (expense), net: Nature Of Business [Line Items] Nature Of Business [Line Items] Nature of the business. Operating Loss Carryforwards Expiration Year Operating loss carryforwards expiration year. R&D tax credit carryforwards expiration year Certain commercial milestone payments for certain licensed antibody product net sales achievements. Certain Commercial Milestone Payments For Certain Licensed Antibody Product Net Sales Achievements Certain commercial milestone payments for certain licensed antibody product net sales achievements Proceeds from sale of pre-funded warrants in offerings, net of issuance costs paid Proceeds from Sale of Pre-Funded Warrants in Offerings, Net of Issuance Costs paid Proceeds from sale of pre-funded warrants in offerings, net of issuance costs paid. Transaction cost. Transaction Cost Transaction cost Current Fiscal Year End Date Current Fiscal Year End Date Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Fair value of stock options vested Pre-funded warrant, Exercise Price Per Warrant Pre-funded warrant, exercise price per warrant. Pre-funded warrant, exercise price per warrant Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less imputed interest Less imputed interest Forward Starting Lease [Member] Forward Starting Lease. Forward Starting Lease [Member] Contingent annual fee upon commercialization percentage of net sales Contingent Annual Fee Upon Commercialization Percentage Of Net Sales Contingent annual fee upon commercialization percentage of net sales. Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Grantee Status Grantee Status [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, Outstanding Related Party Related and Nonrelated Parties [Axis] Change in fair value of contingent value right liability Change In Fair Value Of Contingent Value Right Liability Change In Fair Value Of Contingent Value Right Liability Non rule10b51 arrangement modified flag. Non Rule 10B51 Arr Modified Flag Non-Rule 10b5-1 Arrangement Modified Other Segment Items [Member] Other Segment Items [Member] Other segment items. Common stock reserved for the exercise of stock options Common Stock Authorized And Reserved For Future Issuance Common stock authorized and reserved for future issuance. Entity Registrant Name Entity Registrant Name Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Net Loss Per Share Earnings Per Share [Text Block] Debt Instrument, Maturity Date Maturity Date Entity Emerging Growth Company Entity Emerging Growth Company 2019 Sale Agreement [Member] Two Thousand And Nineteen Sale Agreement [Member] Two thousand and nineteen sale agreement. Money Market Funds [Member] Money Market Funds [Member] Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding-basic Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Total Fair Value Of Options Vested Total fair value of options vested. Line of Credit Facility, Additional Borrowing Capacity Line of credit facility additional borrowing capacity. Additional term loan Out-Of-Plan Inducement Grants [Member] Out-of-plan inducement grants member. Out-Of-Plan Inducement Grants [Member] Marketable Securities [Abstract] Vesting Vesting [Domain] Reduction of the Company's workforce positions Restructuring and Related Cost, Number of Positions Eliminated Development and Regulatory First Indication Second Milestone [Member] Development and regulatory first indication second milestone. Development and Regulatory First Indication Second Milestone [Member] Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period The amount of other comprehensive income unrealized holding gain loss on securities arising during period. Unrealized gain on marketable securities Common stock, shares authorized Common Stock, Shares Authorized Estimated useful lives Property, Plant and Equipment, Useful Life Estimated Useful Life Schedule of Long-Term Debt Instruments [Table Text Block] Summary of Obligations Under the Term Loan Facility Grantee Status Grantee Status [Axis] Proceeds from Issuance of Common Stock Proceeds from the issuance of common stock in pre-closing financing Proceeds from sale of common stock Cash and Cash Equivalents [Abstract] Option Shares Available To Purchase For Underwriter Option Shares Available To Purchase For Underwriter Option shares available to purchase for underwriter. Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Old Gemini [Member] Old Gemini [Member] Old Gemini. Debt Disclosure [Abstract] Long-Term Debt [Text Block] Long-Term Debt Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Financial Instrument [Axis] Development and Regulatory Second Indication First Milestone [Member] Development and regulatory second indication first milestone. Development and Regulatory Second Indication First Milestone [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Term, Outstanding Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] General and Administrative General and Administrative Expense [Member] General and Administrative Expense [Member] Tranche Two [Member] Tranche Two [Member] Tranche two. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Prepaid expenses and other assets Share-Based Payment Arrangement [Abstract] Upfront payment received Amount of Upfront Payment Received Amount of upfront payment received. Impairment of Long-lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] 2017 License Agreement [Member] Two Thousand And Seventeen License Agreement [Member] Two thousand and seventeen license agreement. Collaborative Arrangement and Arrangement Other than Collaborative [Table] Deferred Tax Liabilities Depreciation, Total Depreciation Deferred Tax Liabilities Depreciation Deferred Tax Liabilities Depreciation. Depreciation Unpaid severance costs Unpaid Severance Costs Amount of unpaid severance costs. Federal and state research and development tax credits Effective Income Tax Rate Reconciliation Federal And State Research And Development Tax Credits Effective Income Tax Rate Reconciliation Federal And State Research And Development Tax Credits PIPE Financing [Member] P I P E Financing [Member] PIPE financing. Cybersecurity Risk Role of Management [Text Block] Stock Issued During Period Shares Restricted Stock Award Vested Stock issued during period, shares, restricted stock award, vested. Vesting of restricted common stock (in shares) Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Marketable securities Estimated Fair Value Accounting Policies [Abstract] Aggregate future offer, issuance and sale Sale of Stock Agreement, Aggregate Future Offer, Issuance and Sale Maximum aggregate value of future offer, issuance and sale of shares as agreed upon. Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Merger. Merger [Abstract] Certain development and regulatory milestone payments. Certain Development And Regulatory Milestone Payments Certain development and regulatory milestone payments Cash And Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Income Tax Disclosure [Abstract] Stockholders' equity: Equity, Attributable to Parent [Abstract] Increase Decrease In Accrued External Research and Development Expenses Increase decrease in accrued external research and development expenses Accrued external research and development expenses Supplemental disclosure of non-cash activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Interest income Interest Income, Other Development and Regulatory First Indication First Milestone [Member] Development and regulatory first indication first milestone. Development and Regulatory First Indication First Milestone [Member] Statement [Table] Statement [Table] Segment Information Segment Reporting, Policy [Policy Text Block] Schedule of Property Plant and Equipment Property, Plant and Equipment [Table Text Block] Short Term Bank Loans And NotesPayable Percentage Short Term Bank Loans And NotesPayable Percentage Short term bank loans and notes payable percentage. 2017 Plan [Member] Two Thousand Seventeen Plan [Member] Two thousand seventeen plan. Debt Instruments [Abstract] Subsequent Event [Table] Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock authorized Future payments upon commercialization. Future Payments Upon Commercialization Future payments upon commercialization Entity File Number Entity File Number Segment Reporting Disclosure [Text Block] Segment Information Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash, cash equivalents and restricted cash Earnings Per Share [Abstract] Development and Regulatory Milestone Second Indication [Member] Development and regulatory milestone second indication. Development and Regulatory Milestone Second Indication [Member] Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock-based compensation Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State income taxes, net of federal benefit Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Tax Credit Carryforward [Axis] Loss from operations Operating Income (Loss) Long-Term Debt, Maturity, Year One 2025 Shares issued, price per share Shares Issued, Price Per Share Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Underwritten Offering [Member] Underwritten offering . Underwritten Offering [Member] Entity Shell Company Entity Shell Company Line Of Credit Facility [Table] Line of Credit Facility [Table] Accrued professional fees Accrued Professional Fees, Current Entity Tax Identification Number Entity Tax Identification Number Deferred Issuance Costs on Sale of Pre-funded Warrants in Registered Direct Offering Included in Accounts Payable and Accrued Expenses Deferred Issuance Costs on Sale of Pre-funded Warrants in Registered Direct Offering Included in Accounts Payable and Accrued Expenses Deferred issuance costs on sale of pre-funded warrants in registered direct offering included in accounts payable and accrued expenses Assets Assets [Abstract] Gemini merger. Gemini Merger [Member] Gemini Merger [Member] Entity Current Reporting Status Entity Current Reporting Status Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable at December 31, 2024 Software Development [Member] Internally Developed Software Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Fair value of contingent value right liability Liability incurred under estimated fair value of Company's obligation Asset Acquisition, Contingent Consideration, Liability, Noncurrent Subsequent Events [Abstract] Previously Reported [Member] Previously Reported [Member] Document Fiscal Year Focus Document Fiscal Year Focus Common Stock in Underwritten Offering Net of Issuance Costs Common stock in underwritten offering net of issuance costs. Sale of common stock in underwritten direct offering Cash, cash equivalents and short-term marketable securities Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Share-based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Carrying value Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of December 31, 2024 and December 31, 2023 Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment included in accounts payable and accrued expenses Net proceeds from offering Proceeds from Issuance Initial Public Offering Business Acquisition Business Acquisition [Axis] City Area Code City Area Code William Savage. William Savage [Member] Total current liabilities Liabilities, Current Line of Credit Facility, Lender Line of Credit Facility, Lender [Domain] Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Federal statutory income tax rate Net proceeds, after deducting placement agent fees and offering expenses Net Proceeds From Issuance Of Common Stock Net proceeds from issuance of common stock. Pre-funded warrant, beneficiary ownership limitation percentage Pre-funded warrant, beneficiary ownership limitation percentage Pre-funded warrant, beneficiary ownership limitation percentage Stock Issued During Period Sale of Common Stock in Underwritten Offering Shares Stock issued during period sale of common stock in underwritten offering shares. Sale of common stock in an underwritten offering, (in shares) Organization, Consolidation and Presentation of Financial Statements [Abstract] Local Phone Number Local Phone Number Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding Preferred stock outstanding Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Additional Paid in Capital, Total Additional paid-in capital Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Ending Balance Additional Paid in Capital Proceeds from Sale of Common Stock in at the Market Offerings Proceeds from sale of common stock in at the market offerings. Proceeds from sale of common stock in at-the-market offerings, net of issuance costs paid Income Tax Authority Income Tax Jurisdiction [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Summary of Fair Value of The Warrants to Purchase Shares Schedule Of Fair Value Of The Warrants To Purchase Shares Table [Text Block] The fair value of the warrants to purchase shares. Royalty payments percentage of net product sales if commercialization achieved Royalty Payments Percentage Of Net Product Sales If Commercialization Achieved Royalty payments percentage of net product sales if commercialization achieved. Commitments and Contingencies Disclosure [Abstract] Number of shares issued Shares, Issued Commercialization [Member] Commercialization [Member] Commercialization. At The Market Offering [Member] At The Market Offering [Member] ATM Program [Member] Debt Securities, Available-for-Sale, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Total Amortized Cost Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Operating Lease, Liability, Current Operating lease liabilities, current Sale of pre funded warrant and common stock net proceeds Sale Of Pre Funded Warrant And Common Stock, Net Proceeds Net proceeds from sale of common stock and pre funded warrants. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Foreign currency translation adjustments Income Tax Authority Income Tax Jurisdiction [Domain] Payment for upfront license fee Payment For Upfront License Fee Payment for upfront license fee. Debt Instrument, Interest Rate, Stated Percentage Interest Rate Retained Earnings [Member] Accumulated Deficit [Member] Next Potential Milestone Payments Next potential milestone payment Next potential milestone payments. Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Document Transition Report Document Transition Report Increase (Decrease) in Other Operating Assets, Total Other assets Increase (Decrease) in Other Operating Assets Maximum percent of fair market value of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Lessee, Operating Lease, Liability, to be Paid, Year Two 2026 Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of reporting units Number of Reporting Units Proceeds from Stock Plans Contributions from employee stock purchase plan Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Contribution equals, percentage Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Accrued expenses Concentration of Credit Risk and of Significant Suppliers Concentration Risk, Credit Risk, Policy [Policy Text Block] Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Unamortized debt discount and issuance costs Debt discount and debt issuance costs Nature Of Business [Table] Nature Of Business [Table] Nature of the business. Auditor Firm ID Auditor Firm ID Minimum [Member] Minimum [Member] Clinical Performance Measures [Axis] Clinical Performance Measures [Axis]. Common Stock [Member] Common Stock [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Long-Term Debt, Maturity, Year Two 2026 Accounts Payable and Accrued Liabilities Disclosure [Text Block] Other Accrued Expenses Internal Research and Development [Member] Internal research and development. Internal Research and Development [Member] Investment, Name [Axis] Unvested at December 31, 2020 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Beginning period, December 31, 2023 Ending period, December 31, 2024 Additional Paid-in Capital [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Tranche Two and Three [Member] Tranche two and three. Tranche Two and Three [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operations: Income Statement Location Statement of Income Location, Balance [Domain] Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Other Assets, Noncurrent, Total Other assets Other Assets, Noncurrent Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Aggregate Fair Value of Marketable Securities in unrealized Loss Position Aggregate fair value of marketable securities in unrealized loss position. Aggregate fair value of marketable securities in unrealized loss Segments [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Net increase (decrease) in right-of-use assets related to lease modifications and reassessment events Net Increase Decrease in Right of Use Assets Related to Lease Modifications and Reassessments Net increase decrease in right of use assets related to lease modifications and reassessments. Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and Principles of Consolidation Vesting of restricted common stock Stock Issued During Period Value Restricted Stock Award Vested Stock issued during period, value, restricted stock award, vested. Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Summary of Unrecognized Stock-based Compensation Title and Position [Domain] Consideration Receivable Related to Achievement of Regulatory Consideration receivable related to achievement of regulatory. Consideration receivable related to achievement of regulatory Components of Deferred Tax Assets and Liabilities [Abstract] Tenant Improvement Allowance Reimbursements Tenant improvement allowance reimbursements. Tenant improvement allowance reimbursements Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued Common stock, $0.0001 par value; 100,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 29,865,030 and 24,360,233 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Percentage of number of shares fully diluted capitalization. PercentageOfNumberOfSharesFullyDilutedCapitalization Percentage of number of shares fully diluted capitalization Future Consideration Recievable on Sales Milestones Future consideration recievable on sales milestones. Future consideration recievable on sales milestones Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Two Thousand Twenty One Employee Stock Purchase Plan [Member] 2021 employee stock purchase plan member. 2021 Employee Stock Purchase Plan [Member] Pre Funded Warrants In Follow On Public Offering Net Of Issuance Costs Pre Funded Warrants In Follow On Public Offering Net Of Issuance Costs Pre-funded warrants in follow-on public offering, net of issuance costs Schedule Of Cash And Cash Equivalents [Table] Cash and Cash Equivalent [Table] Condition upon certain milestone payments waived of percentage Condition Upon Certain Milestone Payments Waived Percentage Condition upon certain milestone payments waived percentage. Proceeds from sale of common stock in offerings, net of issuance costs paid Proceeds from Sale of Common Stock in Offerings, Net of Issuance Costs Paid Proceeds from sale of common stock in offerings, net of issuance costs paid. Operating Lease Right Of Use Assets Operating Lease Right Of Use Assets Operating right-of-use assets Operating right-of-use assets Cantor ATM Agreement [Member] Cantor ATM agreement. Cantor ATM Agreement [Member] Long-Term Debt, Maturity, Year Three 2027 Contingent Consideration Type [Domain] Operating Lease, Liability Operating lease liabilities Operating lease liabilities Operating lease liabilities Lease liabilities Future payments upon the achievement of certain development. Future Payments Upon the Achievement of Certain Development Future payments upon the achievement of certain development 2018 License Agreement [Member] Two Thousand And Eighteen License Agreement [Member] Two thousand and eighteen license agreement. Schedule of Accrued Liabilities [Table Text Block] Summary of Other Accrued Expenses Deferred Tax Assets, Operating Loss Carryforwards, Total Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Commitments and Contingencies Commitments and contingencies (Note 15) Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding-diluted Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Significant Segment Expense Categories Lessee, Operating Lease, Liability, to be Paid Total minimum lease payments Cybersecurity Risk Management Third Party Engaged [Flag] Future payments upon sales-based milestones. Future Payments Upon Sales-based Milestones Future payments upon sales based milestones Diluted capitalization of company percentage. Diluted Capitalization Of Company Percentage Number of diluted capitalization shares Entity Small Business Entity Small Business Segment Reporting Information [Line Items] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Convertible Promissory Notes Debt Disclosure [Text Block] Upfront payment Upfront payment. Upfront Payment US Treasury Securities [Member] US Treasury Securities [Member] Rent Expense Operating Leases, Rent Expense Operating Leases, Rent Expense, Total Credit Facility Credit Facility [Axis] Debt Instrument Covenant Minimum Market Capitalization Debt instrument covenant minimum market capitalization. Market capitalization covenant Expired Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Accretion (Amortization) of Discounts and Premiums, Investments Amortization/accretion of investment securities Amortization/accretion of investment securities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at December 31, 2021 Outstanding at December 31, 2023 Outstanding at December 31, 2024 Tranche One [Member] Tranche One [Member] Tranche one. Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Number of investments Disc Medicine, Inc Disc Medicine, Inc [Member] Disc Medicine, Inc [Member] Disc Medicine Inc [Member] State State and Local Jurisdiction [Member] Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use assets obtained in exchange for new operating lease liabilities Rule10b51 arrangement modified flag. Rule 10B51 Arr Modified Flag Rule 10b5-1 Arrangement Modified Valuation allowance Deferred Tax Assets, Valuation Allowance, Total Deferred Tax Assets, Valuation Allowance Valuation allowance Balance (in shares) Temporary Equity, Shares Outstanding Balance (in shares) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive income Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Subsequent Events [Text Block] Subsequent Events OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total Unrealized gain on marketable securities Key Measure of Segment Profit or Loss [Member] Key measure of segment profit or loss. Key Measure of Segment Profit or Loss [Member] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current